Pulmonary hypertension is a group of disorders characterized by elevated mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance. To test our hypothesis that combining two drugs useful in experimental pulmonary hypertension, statins and dehydroepiandrosterone sulfate (DHEA S), is more effective than either agent alone, we induced pulmonary hypertension in adult male rats by exposing them to hypoxia (10%O2) for 3 weeks. We treated them with simvastatin (60 mg/l) and DHEA S (100 mg/l) in drinking water, either alone or in combination. Both simvastatin and DHEA S reduced mPAP (froma mean±s.d. of 34.4±4.4 to 27.6±5.9 and 26.7±4.8 mmHg, respectively), yet their combination was not more effective (26.7±7.9 mmHg). Differences in the degree of oxidative stress (indicated by malondialdehydeplasma concentration),the rate of superoxide production (electron paramagnetic resonance), or blood nitric oxide levels (chemiluminescence) did not explain the lack of additivity of the effect of DHEA S and simvastatin on pulmonary hypertension. We propose that the main mechanism of both drugs on pulmonary hypertension could be their inhibitory effect on 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, which could explain their lack of additivity.

Department of Medical Chemistry and Clinical Biochemistry 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Physiology 2nd Faculty of Medicine Charles University Prague Czech Republic

Military University Hospital Prague Department of Internal Medicine 1st Faculty of Medicine Charles University and Military University Hospital Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc22029568

003      

CZ-PrNML

005      

20230523082052.0

007      

ta

008      

230113s2022 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.934913 $2 doi

035    __

$a (PubMed)36426885

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Krása, Kryštof $7 xx0301779 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Military University Hospital Prague, Department of Internal Medicine, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic

245    10

$a Simvastatin and dehydroepiandrosterone sulfate effects against hypoxic pulmonary hypertension are not additive / $c K. Krása, O. Vajnerová, J. Ďurišová, M. Minaříková, D. Miková, M. Srbová, K. Chalupský, B. Kaftanová, V. Hampl

520    9_

$a Pulmonary hypertension is a group of disorders characterized by elevated mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance. To test our hypothesis that combining two drugs useful in experimental pulmonary hypertension, statins and dehydroepiandrosterone sulfate (DHEA S), is more effective than either agent alone, we induced pulmonary hypertension in adult male rats by exposing them to hypoxia (10%O2) for 3 weeks. We treated them with simvastatin (60 mg/l) and DHEA S (100 mg/l) in drinking water, either alone or in combination. Both simvastatin and DHEA S reduced mPAP (froma mean±s.d. of 34.4±4.4 to 27.6±5.9 and 26.7±4.8 mmHg, respectively), yet their combination was not more effective (26.7±7.9 mmHg). Differences in the degree of oxidative stress (indicated by malondialdehydeplasma concentration),the rate of superoxide production (electron paramagnetic resonance), or blood nitric oxide levels (chemiluminescence) did not explain the lack of additivity of the effect of DHEA S and simvastatin on pulmonary hypertension. We propose that the main mechanism of both drugs on pulmonary hypertension could be their inhibitory effect on 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, which could explain their lack of additivity.

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a zvířata $7 D000818

650    12

$a plicní hypertenze $x farmakoterapie $7 D006976

650    _2

$a simvastatin $x farmakologie $x terapeutické užití $7 D019821

650    _2

$a dehydroepiandrosteronsulfát $7 D019314

650    _2

$a arteria pulmonalis $7 D011651

650    _2

$a hypoxie $x komplikace $x farmakoterapie $x patologie $7 D000860

650    _2

$a dehydroepiandrosteron $x farmakologie $x terapeutické užití $7 D003687

655    _2

$a časopisecké články $7 D016428

700    1_

$a Vajnerová, Olga $7 xx0036859 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Ďurišová, Jana $7 xx0301778 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Minaříková, Marcela $7 xx0301810 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Miková, Dana, $d 1962- $7 xx0062462 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Srbová, Martina, $d 1978- $7 xx0074184 $u Department of Medical Chemistry and Clinical Biochemistry, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Chalupský, Karel, $d 1977- $7 xx0074153 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Kaftanová, Barbora, $d 1984- $7 xx0301775 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Hampl, Václav, $d 1962- $7 nlk20030127352 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 6 (2022), s. 801-810

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36426885 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y - $z 0

990    __

$a 20230113 $b ABA008

991    __

$a 20230523082049 $b ABA008

999    __

$a kom $b bmc $g 1894763 $s 1180893

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2022 $b 71 $c 6 $d 801-810 $e 20221125 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

LZP    __

$b NLK198 $a Pubmed-20230113